-
-
-
-
-
-
-
Stemline Therapeutics Announces Preliminary 2019 Net Revenues for ELZONRISĀ® (tagraxofusp) and Highlights Commercial and Clinical Growth Drivers
-
-
-
-
-
-
-
Stemline Therapeutics Reports First Quarter 2019 Financial Results
-
-
-
-
-
-
-
Stemline Therapeutics Reports Second Quarter 2018 Financial Results
-
-
-
-
-
-
-
Stemline Therapeutics Reports Second Quarter 2017 Financial Results
-
-
-
-
-
-
-
Stemline Therapeutics (STML) Tops Q1 EPS by 8c
-
-
-
-
-
-
-
Stemline Therapeutics Reports Third Quarter 2015 Financial Results
-
-
-
-
-
-
-
Stemline Therapeutics (STML) Misses Q4 EPS by 2c
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

